Literature DB >> 15086664

Drug-induced lithium toxicity in the elderly: a population-based study.

David N Juurlink1, Muhammad M Mamdani, Alexander Kopp, Paula A Rochon, Kenneth I Shulman, Donald A Redelmeier.   

Abstract

OBJECTIVES: To study the association between hospital admission for lithium toxicity and the use of diuretics, angiotensin-converting enzyme (ACE) inhibitors, and nonsteroidal antiinflammatory drugs (NSAIDs) in the elderly.
DESIGN: Population-based nested case-control study.
SETTING: Ontario, Canada. PARTICIPANTS: Ontario residents aged 66 and older treated with lithium. MEASUREMENTS: Estimated relative risk of hospital admission for lithium toxicity.
RESULTS: From January 1992 to December 2001, 10,615 elderly patients continuously receiving lithium were identified, of whom 413 (3.9%) were admitted to the hospital at least once for lithium toxicity. After adjustment for potential confounders, a dramatically increased risk of lithium toxicity was seen within a month of initiating treatment with a loop diuretic (relative risk (RR)=5.5, 95% confidence interval (CI)=1.9-16.1) or an ACE inhibitor (RR=7.6, 95% CI=2.6-22.0). Conversely, neither thiazide diuretics nor NSAIDs were independently associated with a significantly increased risk of hospitalization for lithium toxicity.
CONCLUSION: The use of loop diuretics or ACE inhibitors significantly increases the risk of hospitalization for lithium toxicity, particularly in naïve recipients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15086664     DOI: 10.1111/j.1532-5415.2004.52221.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  32 in total

1.  The Combination of Lithium and ACE Inhibitors: Hazardous, Critical, Possible?

Authors:  Leif Hommers; Matthias Fischer; Christine Reif-Leonhard; Bruno Pfuhlmann; Jürgen Deckert; Stefan Unterecker
Journal:  Clin Drug Investig       Date:  2019-05       Impact factor: 2.859

2.  Delirium due to a drug-drug interaction of lithium and an NSAID.

Authors:  R A Faaij; G Ziere; R Zietse; T J M Van der Cammen
Journal:  J Nutr Health Aging       Date:  2009-03       Impact factor: 4.075

Review 3.  Molecular mechanisms in lithium-associated renal disease: a systematic review.

Authors:  Soham Rej; Shamira Pira; Victoria Marshe; André Do; Dominique Elie; Karl J Looper; Nathan Herrmann; Daniel J Müller
Journal:  Int Urol Nephrol       Date:  2016-06-29       Impact factor: 2.370

Review 4.  Lithium Toxicity in Older Adults: a Systematic Review of Case Reports.

Authors:  Meng Sun; Nathan Herrmann; Kenneth I Shulman
Journal:  Clin Drug Investig       Date:  2018-03       Impact factor: 2.859

5.  Acute renal and neurotoxicity in older lithium users: How can we manage and prevent these events in patients with late-life mood disorders?

Authors:  Vincent Laliberté; Ching Yu; Soham Rej
Journal:  J Psychiatry Neurosci       Date:  2015-07       Impact factor: 6.186

6.  Hypertensive bipolar: chronic lithium toxicity in patients taking ACE inhibitor.

Authors:  Ruziana Masiran; Mohammad Firdaus Abdul Aziz
Journal:  BMJ Case Rep       Date:  2017-08-28

7.  Chronic lithium toxicity: Considerations and systems analysis.

Authors:  Nora MacLeod-Glover; Ryan Chuang
Journal:  Can Fam Physician       Date:  2020-04       Impact factor: 3.275

8.  A population-based study of the drug interaction between proton pump inhibitors and clopidogrel.

Authors:  David N Juurlink; Tara Gomes; Dennis T Ko; Paul E Szmitko; Peter C Austin; Jack V Tu; David A Henry; Alex Kopp; Muhammad M Mamdani
Journal:  CMAJ       Date:  2009-01-28       Impact factor: 8.262

9.  Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study.

Authors:  Catherine M Kelly; David N Juurlink; Tara Gomes; Minh Duong-Hua; Kathleen I Pritchard; Peter C Austin; Lawrence F Paszat
Journal:  BMJ       Date:  2010-02-08

Review 10.  Adverse drug events as a cause of hospitalization in older adults.

Authors:  Fabio Salvi; Annalisa Marchetti; Federica D'Angelo; Massimo Boemi; Fabrizia Lattanzio; Antonio Cherubini
Journal:  Drug Saf       Date:  2012-01       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.